[Efficacy and tolerance of azithromycin in respiratory tract infections in children]

Minerva Pediatr. 1995 Jun;47(6):249-60.
[Article in Italian]

Abstract

This study was carried out to determine the clinical efficacy and the clinical safety of azithromycin in a group of children with acute respiratory tract infections. The study involved 82 children treated with a single daily 10 mg/kg dose of azithromycin for three consecutive days. 7 days later, the overall clinical response was 100% (cure and improvement): bacteriological cure was achieved in 97.5% of the patients treated. Recurrences were never observed. Side effects not requiring interruption of therapy were observed in 3 patients (3.6%). The side effects were gastrointestinal disturbances. In conclusion azithromycin showed a remarkably clinical efficacy for treatment of acute respiratory infections in children. Tolerability and therapeutic compliance were excellent.

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use*
  • Azithromycin / administration & dosage
  • Azithromycin / pharmacology*
  • Azithromycin / therapeutic use*
  • Bordetella pertussis / drug effects
  • Bordetella pertussis / isolation & purification
  • Child
  • Child, Preschool
  • Drug Tolerance
  • Female
  • Haemophilus / drug effects
  • Haemophilus / isolation & purification
  • Humans
  • Infant
  • Male
  • Moraxella catarrhalis / drug effects
  • Moraxella catarrhalis / isolation & purification
  • Mycoplasma pneumoniae / drug effects
  • Mycoplasma pneumoniae / isolation & purification
  • Respiratory Tract Infections / diagnosis*
  • Respiratory Tract Infections / microbiology
  • Retrospective Studies
  • Streptococcus / drug effects
  • Streptococcus / isolation & purification
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Azithromycin